Francesca Cianci

Via Celoria 26
Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 20, 2026

Repurposing Triamterene as Chloride Intracellular Channel 1 Inhibitor via Ligand-Based Approach: A Novel Adjuvant Treatment for Glioblastoma.

Repurposing Triamterene as Chloride Intracellular Channel 1 Inhibitor via Ligand-Based Approach: A Novel Adjuvant Treatment for Glioblastoma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 16, 2025

An OSMR-CLIC1 cross talk drives key oncogenic pathways in glioblastoma.

An OSMR-CLIC1 cross talk drives key oncogenic pathways in glioblastoma.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 01, 2025

An oncostatin M receptor and chloride intracellular channel 1 crosstalk drives key oncogenic pathways in glioblastoma.

An oncostatin M receptor and chloride intracellular channel 1 crosstalk drives key oncogenic pathways in glioblastoma.

Journal: Signal transduction and targeted therapy

Published: May 23, 2025

Correction to: Human antimicrobial peptide LL-37 contributes to Alzheimer's disease progression.

Correction to: Human antimicrobial peptide LL-37 contributes to Alzheimer's disease progression.

Journal: Molecular psychiatry

Published: April 04, 2023

Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.

Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 03, 2021

Transmembrane Chloride Intracellular Channel 1 (tmCLIC1) as a Potential Biomarker for Personalized Medicine.

Transmembrane Chloride Intracellular Channel 1 (tmCLIC1) as a Potential Biomarker for Personalized Medicine.

Journal: Journal of personalized medicine

Published: May 04, 2021

Human antimicrobial peptide LL-37 contributes to Alzheimer's disease progression.

Human antimicrobial peptide LL-37 contributes to Alzheimer's disease progression.

Journal: Molecular psychiatry

Published: June 09, 2020

CLIC1 Protein Accumulates in Circulating Monocyte Membrane during Neurodegeneration.

CLIC1 Protein Accumulates in Circulating Monocyte Membrane during Neurodegeneration.

Journal: International journal of molecular sciences

Published: January 19, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026